Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
2002-08-08
Original market date: See footnote 1
1997-03-20
Product name:
MYGRACARE
DIN:
02230012 Electronic product monograph is not available
Company:
ENZYMATIC THERAPY (CANADA) INC.
2696 Nootka St
Vancouver
British Columbia
Canada
V5M 3M5
Class:
Human
Dosage form(s):
Capsule
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
OTC
American Hospital Formulary Service (AHFS): See footnote 3
92:01.00* See footnote6
Anatomical Therapeutic Chemical (ATC): See footnote 4
Active ingredient group (AIG) number:See footnote5
0119569005
Active ingredient(s) | Strength |
---|---|
FEVERFEW | 475 MG / CAP |